CorVel combines durable claims management relationships, exceptional capital efficiency, and automation-driven earnings growth, although its premium valuation requires sustained execution and leaves limited room for disappointment.
Quality Compounder
542 tickers in this investment thesisZebra Technologies combines entrenched enterprise identification systems, growing automation demand, and strong free cash flow with an attractive valuation, although memory-cost inflation and cyclical hardware spending threaten margin recovery.
DuPont's focused specialty-materials portfolio and improving margins support sustainable earnings growth, but modest capital efficiency, legacy liabilities and an already reasonable valuation limit near-term upside.
Waters combines durable laboratory instrumentation, recurring consumables, and expanding diagnostics exposure with meaningful synergy opportunities, but elevated leverage and demanding cash-flow expectations limit its near-term investment appeal.
Coca-Cola Europacific Partners combines a durable beverage distribution moat, resilient cash flow and disciplined shareholder returns, but elevated valuation and substantial leverage limit near-term upside.
AMETEK combines high-margin precision instrumentation, durable customer switching costs, and acquisition-driven compounding, while elevated debt and Indicor integration requirements create meaningful execution risks.
Apollo's integrated private-credit and retirement platform offers durable recurring earnings growth, but insurance valuation volatility and credit-cycle sensitivity constrain near-term conviction.
Itaú Unibanco combines a durable Brazilian banking franchise, strong recurring ROE, and attractive earnings multiples, although political uncertainty, currency depreciation, and credit-cycle deterioration could constrain shareholder returns.
Amgen combines a durable biotechnology franchise, strong cash generation, and growing specialty medicines, but elevated valuation, biosimilar erosion, and acquisition-related leverage constrain prospective returns.
Leidos offers durable defense technology demand, strong cash generation, and an attractive valuation, although healthcare contract weakness and acquisition-related leverage could constrain earnings growth.
Assurant combines recurring specialty insurance and protection-service earnings with strong cash generation and disciplined buybacks, although catastrophe exposure, partner concentration, and a higher share price constrain its margin of safety.
Ball's global aluminum packaging franchise, improving comparable EPS, and disciplined buybacks support long-term value creation, but weak cash conversion, leverage, and a premium to packaging peers limit near-term upside.